1. Home
  2. WVE vs NUTX Comparison

WVE vs NUTX Comparison

Compare WVE & NUTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

HOLD

Current Price

$6.06

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Logo Nutex Health Inc.

NUTX

Nutex Health Inc.

HOLD

Current Price

$182.27

Market Cap

1.1B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
WVE
NUTX
Founded
2012
2011
Country
Singapore
United States
Employees
N/A
944
Industry
Biotechnology: Pharmaceutical Preparations
Retail: Computer Software & Peripheral Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.1B
IPO Year
2015
2009

Fundamental Metrics

Financial Performance
Metric
WVE
NUTX
Price
$6.06
$182.27
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
16
2
Target Price
$29.81
$252.50
AVG Volume (30 Days)
3.1M
110.7K
Earning Date
04-28-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
7.93
EPS
N/A
6.52
Revenue
$3,704,000.00
$875,257,000.00
Revenue This Year
N/A
$6.12
Revenue Next Year
$85.67
$4.04
P/E Ratio
N/A
$28.25
Revenue Growth
149.43
82.36
52 Week Low
$5.02
$77.21
52 Week High
$21.73
$204.00

Technical Indicators

Market Signals
Indicator
WVE
NUTX
Relative Strength Index (RSI) 48.57 68.05
Support Level $6.02 $90.50
Resistance Level $6.31 $192.69
Average True Range (ATR) 0.32 11.19
MACD 0.07 1.26
Stochastic Oscillator 57.95 68.00

Price Performance

Historical Comparison
WVE
NUTX

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About NUTX Nutex Health Inc.

Nutex Health Inc is a physician-led, healthcare services and operations company with various hospital facilities in the U.S. states (hospital division), and a primary care-centric, risk-bearing population health management division. The company has three segments: the hospital division, the PHM division, and the real estate division. The hospital division implements and operates health care models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management (PHM) division owns and operates provider networks such as independent physician associations (IPAs). The Real Estate Entities own the land and hospital buildings which are leased to its hospital entities. The majority of the revenue is derived from the Hospital division.

Share on Social Networks: